Stress Turns Microglia Into Two Different Kinds of Old People ✎ bioRxiv

Original: "Genotoxic and metabolic stress drive divergent senescence programs in human microglia"
· B Platt, N Vincy Jose, E Kang, S Janssens
b42w:2609.90019 · the paper's page · 2026-09-04 · All rights reserved · independent analysis · 2 min
DNA damage and excess glucose set off different aging programs in the brain's immune cells.

In the brain of an elderly person there are cells whose job is to clear out the trash and protect neurons. But with age they become a source of trouble themselves: they stop dividing and start constantly releasing inflammatory molecules. It's a bit like two old men who arrive at the same nursing home by different roads. One ends up there after an accident that wrecked his body, the other after long years of overeating sweets. Both wind up in the same place, but they look and behave differently.

Scientists took human immune cells from the brain and subjected them to two kinds of stress. The first was DNA damage, as if the cell had been hit by radiation or a toxic drug. The second was excess glucose, as if the cell had been forced to live in sugar syrup. Both stresses made the cells enlarge, stop dividing and begin releasing inflammatory substances. But past that point the paths diverged.

DNA damage activated the protein p53, which ordered the cell to stop. At the same time a broad set of inflammatory molecules was released, as if the cell were shouting for help to all its neighbors at once. Excess glucose additionally switched on the protein p16 and a different, more selective set of signals, as if the cell were whispering to only certain neighbors.

The difference also shows up in the cell's power plants, the mitochondria. Under DNA damage their number fell, while under excess glucose it rose, but to no avail: the cell couldn't use that energy efficiently. In both cases the cells didn't die; they stayed alive in a damaged state. That explains why dysfunctional immune cells accumulate in the brains of elderly people.

Cell aging used to be thought of as a single program. Now it's clear there are at least two programs, and they depend on which stress the cell went through. That matters for treating diseases in which such cells play a role, Alzheimer's disease among them.

Back to the image of the two old men: now it's clear that in the nursing home they aren't just different people, they are people with different medical histories. One needs treatment for the aftermath of an injury, the other for the aftermath of diabetes. The same goes for cells: therapy has to take into account which particular stress drove them into aging. For now scientists are only feeling out these differences, but the road is already in sight.

Doxorubicin, used here to damage DNA, was originally an antitumor antibiotic that itself induces cellular senescence. And the glucose concentration of 200 mM is 36 times higher than the normal level in human blood, which highlights how extreme the metabolic stress in the model is.

Take the whole work

Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.

Concepts
epigenetic aging cellular senescence epigenetic clock